Global Embolotherapy Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
The Global Embolotherapy Market is expected to grow from USD 3,012.24 Million in 2018 to USD 5,236.24 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.21%.
The positioning of the Global Embolotherapy Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Embolotherapy Market including are Abbott Laboratories, Acandis GmbH, Balt Extrusion, Boston Scientific Corporation, BTG plc, Cook Medical Incorporated, Johnson & Johnson, Kaneka Corporation, Medtronic plc, Meril Life Sciences Pvt., Ltd., Merit Medical Systems Inc, Penumbra, Inc., Sirtex Medical Limited, Stryker Corporation, and Terumo Corporation.
On the basis of Product, the Global Embolotherapy Market is studied across Embolic Agents and Support Devices.
On the basis of Disease Indication, the Global Embolotherapy Market is studied across Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, and Urological & Nephrological Disorders.
On the basis of Procedure, the Global Embolotherapy Market is studied across Transarterial Chemoembolization, Transcatheter Arterial Embolization, and Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy.
On the basis of End User, the Global Embolotherapy Market is studied across Ambulatory Surgery Centers and Hospitals and Clinics.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Embolotherapy Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Embolotherapy Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Embolotherapy Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Embolotherapy Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Embolotherapy Market
The report answers questions such as:
1. What is the market size of Embolotherapy market in the Global?
2. What are the factors that affect the growth in the Global Embolotherapy Market over the forecast period?
3. What is the competitive position in the Global Embolotherapy Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Embolotherapy Market?
5. What are the opportunities in the Global Embolotherapy Market?
6. What are the modes of entering the Global Embolotherapy Market?
The positioning of the Global Embolotherapy Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Embolotherapy Market including are Abbott Laboratories, Acandis GmbH, Balt Extrusion, Boston Scientific Corporation, BTG plc, Cook Medical Incorporated, Johnson & Johnson, Kaneka Corporation, Medtronic plc, Meril Life Sciences Pvt., Ltd., Merit Medical Systems Inc, Penumbra, Inc., Sirtex Medical Limited, Stryker Corporation, and Terumo Corporation.
On the basis of Product, the Global Embolotherapy Market is studied across Embolic Agents and Support Devices.
On the basis of Disease Indication, the Global Embolotherapy Market is studied across Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, and Urological & Nephrological Disorders.
On the basis of Procedure, the Global Embolotherapy Market is studied across Transarterial Chemoembolization, Transcatheter Arterial Embolization, and Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy.
On the basis of End User, the Global Embolotherapy Market is studied across Ambulatory Surgery Centers and Hospitals and Clinics.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Embolotherapy Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Embolotherapy Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Embolotherapy Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Embolotherapy Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Embolotherapy Market
The report answers questions such as:
1. What is the market size of Embolotherapy market in the Global?
2. What are the factors that affect the growth in the Global Embolotherapy Market over the forecast period?
3. What is the competitive position in the Global Embolotherapy Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Embolotherapy Market?
5. What are the opportunities in the Global Embolotherapy Market?
6. What are the modes of entering the Global Embolotherapy Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Embolotherapy Market
3.2. Opportunities in the Embolotherapy Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing target patient population
4.2.1.2. Rising patient preference for minimally invasive procedures
4.2.1.3. Investment & funding by government and private organizations
4.2.1.4. Technology advancements in embolotherapy devices
4.2.1.5. Favorable reimbursement scenario for minimally invasive surgeries
4.2.2. Restraints
4.2.2.1. Lack of sufficient evidence & unfavorable regulatory scenario
4.2.2.2. Strong market positioning of alternative therapies
4.2.3. Opportunities
4.2.3.1. Growth opportunities in emerging markets
4.2.3.2. Expanding applications of embolization devices
4.2.4. Challenges
4.2.4.1. Lack of skilled surgeons
4.2.4.2. High cost and resulting difficulties in accessing embolization in developing countries
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL EMBOLOTHERAPY MARKET, BY PRODUCT
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Embolic Agents
5.3.1. Detachable Balloons
5.3.2. Embolic Coils
5.3.3. Embolic Plug Systems
5.3.4. Liquid Embolic Agents
5.3.5. Microspheres
5.4. Support Devices
5.4.1. Guidewires
5.4.2. Microcatheters
6. GLOBAL EMBOLOTHERAPY MARKET, BY DISEASE INDICATION
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Cancer
6.4. Gastrointestinal Disorders
6.5. Neurological Diseases
6.6. Peripheral Vascular Disease
6.7. Urological & Nephrological Disorders
7. GLOBAL EMBOLOTHERAPY MARKET, BY PROCEDURE
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Transarterial Chemoembolization
7.4. Transcatheter Arterial Embolization
7.5. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
8. GLOBAL EMBOLOTHERAPY MARKET, BY END USER
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Ambulatory Surgery Centers
8.4. Hospitals and Clinics
9. GLOBAL EMBOLOTHERAPY MARKET, BY GEOGRAPHY
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Americas
9.3.1. Overview
9.3.2. Market Sizing & Forecasting
9.3.3. Argentina
9.3.4. Brazil
9.3.5. Canada
9.3.6. Mexico
9.3.7. United States
9.4. Asia-Pacific
9.4.1. Overview
9.4.2. Market Sizing & Forecasting
9.4.3. Australia
9.4.4. China
9.4.5. India
9.4.6. Japan
9.5. Europe, Middle East & Africa
9.5.1. Overview
9.5.2. Market Sizing & Forecasting
9.5.3. France
9.5.4. Germany
9.5.5. Italy
9.5.6. Spain
9.5.7. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. 360iResearch FPNV Positioning Matrix for Global Embolotherapy Market
10.2. Market Vendor Ranking Analysis for Global Embolotherapy Market
10.3. Competitive News Feed Analysis for Global Embolotherapy Market
11. COMPANY USABILITY PROFILES
11.1. Abbott Laboratories
11.1.1. Overview
11.1.2. Strategy
11.1.3. SWOT
11.2. Acandis GmbH
11.2.1. Overview
11.2.2. Strategy
11.2.3. SWOT
11.3. BTG plc
11.3.1. Overview
11.3.2. Strategy
11.3.3. SWOT
11.4. Balt Extrusion
11.4.1. Overview
11.4.2. Strategy
11.4.3. SWOT
11.5. Boston Scientific Corporation
11.5.1. Overview
11.5.2. Strategy
11.5.3. SWOT
11.6. Cook Medical Incorporated
11.7. Johnson & Johnson
11.8. Kaneka Corporation
11.9. Medtronic plc
11.10. Meril Life Sciences Pvt., Ltd.
11.11. Merit Medical Systems Inc
11.12. Penumbra, Inc.
11.13. Sirtex Medical Limited
11.14. Stryker Corporation
11.15. Terumo Corporation
12. APPENDIX
12.1. Discussion Guide
12.2. Top Reports
12.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.3. Author Details
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Embolotherapy Market
3.2. Opportunities in the Embolotherapy Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing target patient population
4.2.1.2. Rising patient preference for minimally invasive procedures
4.2.1.3. Investment & funding by government and private organizations
4.2.1.4. Technology advancements in embolotherapy devices
4.2.1.5. Favorable reimbursement scenario for minimally invasive surgeries
4.2.2. Restraints
4.2.2.1. Lack of sufficient evidence & unfavorable regulatory scenario
4.2.2.2. Strong market positioning of alternative therapies
4.2.3. Opportunities
4.2.3.1. Growth opportunities in emerging markets
4.2.3.2. Expanding applications of embolization devices
4.2.4. Challenges
4.2.4.1. Lack of skilled surgeons
4.2.4.2. High cost and resulting difficulties in accessing embolization in developing countries
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL EMBOLOTHERAPY MARKET, BY PRODUCT
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Embolic Agents
5.3.1. Detachable Balloons
5.3.2. Embolic Coils
5.3.3. Embolic Plug Systems
5.3.4. Liquid Embolic Agents
5.3.5. Microspheres
5.4. Support Devices
5.4.1. Guidewires
5.4.2. Microcatheters
6. GLOBAL EMBOLOTHERAPY MARKET, BY DISEASE INDICATION
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Cancer
6.4. Gastrointestinal Disorders
6.5. Neurological Diseases
6.6. Peripheral Vascular Disease
6.7. Urological & Nephrological Disorders
7. GLOBAL EMBOLOTHERAPY MARKET, BY PROCEDURE
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Transarterial Chemoembolization
7.4. Transcatheter Arterial Embolization
7.5. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
8. GLOBAL EMBOLOTHERAPY MARKET, BY END USER
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Ambulatory Surgery Centers
8.4. Hospitals and Clinics
9. GLOBAL EMBOLOTHERAPY MARKET, BY GEOGRAPHY
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Americas
9.3.1. Overview
9.3.2. Market Sizing & Forecasting
9.3.3. Argentina
9.3.4. Brazil
9.3.5. Canada
9.3.6. Mexico
9.3.7. United States
9.4. Asia-Pacific
9.4.1. Overview
9.4.2. Market Sizing & Forecasting
9.4.3. Australia
9.4.4. China
9.4.5. India
9.4.6. Japan
9.5. Europe, Middle East & Africa
9.5.1. Overview
9.5.2. Market Sizing & Forecasting
9.5.3. France
9.5.4. Germany
9.5.5. Italy
9.5.6. Spain
9.5.7. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. 360iResearch FPNV Positioning Matrix for Global Embolotherapy Market
10.2. Market Vendor Ranking Analysis for Global Embolotherapy Market
10.3. Competitive News Feed Analysis for Global Embolotherapy Market
11. COMPANY USABILITY PROFILES
11.1. Abbott Laboratories
11.1.1. Overview
11.1.2. Strategy
11.1.3. SWOT
11.2. Acandis GmbH
11.2.1. Overview
11.2.2. Strategy
11.2.3. SWOT
11.3. BTG plc
11.3.1. Overview
11.3.2. Strategy
11.3.3. SWOT
11.4. Balt Extrusion
11.4.1. Overview
11.4.2. Strategy
11.4.3. SWOT
11.5. Boston Scientific Corporation
11.5.1. Overview
11.5.2. Strategy
11.5.3. SWOT
11.6. Cook Medical Incorporated
11.7. Johnson & Johnson
11.8. Kaneka Corporation
11.9. Medtronic plc
11.10. Meril Life Sciences Pvt., Ltd.
11.11. Merit Medical Systems Inc
11.12. Penumbra, Inc.
11.13. Sirtex Medical Limited
11.14. Stryker Corporation
11.15. Terumo Corporation
12. APPENDIX
12.1. Discussion Guide
12.2. Top Reports
12.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.3. Author Details
